Search - tctmd.com

Displaying 1 - 20 of 54

Sort: Relevancy | Date

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

News Daily News

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Todd Neale

April 28, 2016

Presentation

Drug-Coated Balloon for Revascularization of Infrapopliteal Arteries

Presenter: Salvatore Cassese

April 28, 2016

News Conference News ISET 2016

Investigational Metallic-Tipped Catheter Shows Early PAD Promise in CTOs, Calcified Lesions

Michael O'Riordan

February 15, 2016

News Industry News

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

February 08, 2016

News Industry News

First Intervention with the Self-Apposing Drug-Eluting Stent for Lower Limbs broadcasted live at LINC international congress

January 28, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Industry News

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

November 30, 2015

News Daily News

PAD Patients Do Better When Endovascular Therapy Added to Exercise Program

Caitlin E. Cox

November 15, 2015

News Daily News

A los Pacientes EAP les Va mejor cuando el Tratamiento Endovascular se Suma a un Programa de Ejercicio Físico

Caitlin E. Cox

November 15, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Daily News

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

L.A. McKeown

October 26, 2015

News Industry News

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

September 29, 2015

News Daily News

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

L.A. McKeown

September 23, 2015

News Daily News

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

L.A. McKeown

September 23, 2015

News Daily News

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

L.A. McKeown

September 23, 2015

News Industry News

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

August 14, 2015

News Daily News

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

L.A. McKeown

August 05, 2015

News Daily News

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

L.A. McKeown

August 05, 2015

News Industry News

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

August 03, 2015

Advertisement

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Drug-Coated Balloon for Revascularization of Infrapopliteal Arteries

Investigational Metallic-Tipped Catheter Shows Early PAD Promise in CTOs, Calcified Lesions

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

First Intervention with the Self-Apposing Drug-Eluting Stent for Lower Limbs broadcasted live at LINC international congress

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

PAD Patients Do Better When Endovascular Therapy Added to Exercise Program

A los Pacientes EAP les Va mejor cuando el Tratamiento Endovascular se Suma a un Programa de Ejercicio Físico

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease

La Diálisis es un Predictor Importante de Resultados Adversos Post-Intervención Endovascular por ICE

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content